跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BN-9
首页
药物
BN-9
BN-9
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof
US 11167006 B2
申请人: SHANGHAI TIANCI LIFE SCIENCE DEV CO LTD
优先权: 2016
CN
US
4 件公开
Gastrin and cholecystokinin receptor ligands (III)
US 7034048 B2
申请人: BLACK JAMES FOUNDATION
优先权: 2000
US
2 件公开
Gastrin and cholecystokinin receptor lignads (iv)
US 7105558 B2
申请人: BLACK JAMES FOUNDATION
优先权: 2000
US
2 件公开
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
US 6979682 B2
申请人: UNIV LOUISIANA STATE
优先权: 2002
US
2 件公开
Synthesis and use of thienotriazolodiazepines
US 6987105 B2
申请人: UNIV LOUISIANA STATE
优先权: 2003
US
2 件公开
Gastrin and cholecystokinin receptor ligands(II)
US 6878734 B2
申请人: BLACK JAMES FOUNDATION
优先权: 2000
US
Pharmaceutical compositions comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands
US 2003195240 A1
申请人: KALINDJIAN SARKIS BARRET
优先权: 2000
US
Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US 6936714 B2
申请人: UNIV COLUMBIA
优先权: 2003
US
Sustained release agent of curcumin and preparation method thereof
CN 1969815 A
申请人: UNIV ZHEJIANG TECHNOLOGY
优先权: 2006
CN
Method for preparing flavonoid dimeric compound as well as medium and preparation method thereof
CN 101570530 B
申请人: SHANGHAI INST PHARM INDUSTRY
优先权: 2008
CN
第 1 / 2 页
上一页
下一页
药物
反馈